Bulk Pharmaceutical API Sources for TREANDA

Bulk Pharmaceutical API Sources for TREANDA

Vendor	Vendor Homepage	Vendor Sku	API Url
NovoSeek		77082
MolPort		MolPort-006-823-040
AAA Chemistry		AR-1G0244

Bulk API Sources for TREANDA (Bendamustine Hydrochloride)

Last updated: February 20, 2026

What are the major sources of bulk Active Pharmaceutical Ingredient (API) for TREANDA (Bendamustine Hydrochloride)?

TREANDA (bendamustine hydrochloride) is an FDA-approved chemotherapeutic agent used primarily for chronic lymphocytic leukemia (CLL) and non-Hodgkin lymphoma (NHL). Its manufacturing relies on several key suppliers capable of meeting pharmaceutical-grade standards (GMP compliance) and supply chain demands.

Who are the leading API manufacturers for bendamustine hydrochloride?

1. Cephalon Inc./Teva Pharmaceuticals

• Original developer of TREANDA.
• Historically, managed API manufacturing through internal facilities and licensing agreements.

2. Fresenius Kabi

• Known for producing generic APIs.
• Has supplied bendamustine hydrochloride APIs for biosimilar or generic versions.

3. Regeneron Pharmaceuticals (Potential supplier)

• Engages in API development for oncology agents, including bendamustine derivatives, but specific API manufacturing details remain limited.

4. Indovax/Biocon

• Indian biotech companies working on generic APIs, including bendamustine hydrochloride.
• Capable of GMP-grade manufacturing, with supply agreements potentially in place for global markets.

5. Contract Manufacturing Organizations (CMOs)

• Several international CMOs, including Brinterpharma, Sino Biopharmaceuticals, and Hetero Labs, manufacture bendamustine hydrochloride API.
• These suppliers often serve multiple pharmaceutical companies under confidential agreements.

Key Considerations in API sourcing

Aspect	Details
GMP Compliance	All suppliers must meet current Good Manufacturing Practices (cGMP), enforced by regulatory agencies like the FDA, EMA, etc.
Regulatory Approvals	Suppliers with approved API facilities listed in Food and Drug Administration (FDA) and European Medicines Agency (EMA) databases avoid regulatory delays.
Production Capacity	High-volume capacity is critical, as API is needed for global distribution, with some suppliers claiming production rates exceeding 100 kg/month.
Quality Certification	Certificates of Analysis (CoA), stability data, and batch consistency are mandatory for API transfer to pharmaceutical manufacturers.

Regional API manufacturing landscape

Region	Notable API Manufacturers	Regulatory Status
North America	Teva, Fresenius Kabi	FDA-approved facilities
Europe	Teva, Sandoz	EMA-approved, GMP-certified
Asia	Hetero Labs, Biocon, Jiangsu Hengrui	WHO-GMP, MHRA certifications

Adoption of APIs by pharmaceutical companies

Manufacturers typically secure APIs through licensed agreements with the suppliers listed above or via approved CMOs. Procurement involves risk mitigation through multiple sources, especially for APIs sourcing from regions with variable regulatory oversight.

Conclusion

The primary sources for bulk API of TREANDA (bendamustine hydrochloride) include established pharmaceutical companies such as Teva Pharmaceuticals, Fresenius Kabi, and Indian CMOs like Hetero Labs and Biocon. Their production capacity, compliance, and international regulatory status influence procurement decisions.

---

Key Takeaways

• API procurement for TREANDA depends on suppliers with GMP certification, proven quality, and sufficient production capacity.
• Teva Pharmaceuticals remains the original API source, with multiple generic manufacturers now active globally.
• Indian and Chinese CMOs have increased their role in API supply, often providing cost-effective alternatives.
• Regulatory alignment and supply chain transparency are critical for global API sourcing.

---

FAQs

Q1: Can I confirm the current approved API suppliers for TREANDA?
A1: No. The API supply chain is confidential, but the original manufacturer was Teva Pharmaceuticals. Recent generic API suppliers include Indian firms like Hetero Labs and Biocon, with others possibly involved under licensing agreements.

Q2: How do regulatory agencies verify API quality across different regions?
A2: Agencies evaluate GMP compliance through site inspections, certification, and review of manufacturing practices. Suppliers listed in official databases like the FDA's Drug Master File (DMF) are accepted as qualified.

Q3: What are the risks of sourcing bendamustine API from multiple suppliers?
A3: Risks include batch inconsistency, regulatory non-compliance, or supply disruptions. Multisourcing requires robust quality agreements and validation protocols.

Q4: How does API price influence procurement?
A4: API costs vary by region, manufacturing scale, and certification. Cost-driven decisions often favor Indian or Chinese suppliers, provided quality standards are met.

Q5: Are there biosimilar or generic versions using different APIs?
A5: Yes. Several manufacturers produce bendamustine hydrochloride generics, which may utilize APIs sourced from various suppliers, subject to regulatory approval.

---

References

1. U.S. Food and Drug Administration. (2022). List of Drug Master Files.
2. European Medicines Agency. (2022). Certificate of Suitability (CEP) databases.
3. MarketWatch. (2023). Oncology API Market Analysis.
4. Indian Pharmaceutical Alliance. (2023). API manufacturing capacity and certifications.
5. GlobalData. (2022). Oncology pharmaceutical supply chains.